Skip to main content
Ajooni Biotech Limited logo

Ajooni Biotech Limited — Investor Relations & Filings

Ticker · AJOONI ISIN · INE820Y01021 LEI · 335800OAKJWKHF49O339 National Stock Exchange of India Manufacturing
Filings indexed 562 across all filing types
Latest filing 2024-12-24 Board/Management Inform…
Country IN India
Listing National Stock Exchange of India AJOONI

About Ajooni Biotech Limited

https://www.ajoonibiotech.com

Ajooni Biotech Limited specializes in the production and distribution of animal healthcare solutions and nutritional supplements. The company focuses on the livestock sector, offering a comprehensive range of products including compounded cattle feed, mineral mixtures, and specialized supplements formulated to enhance milk productivity and overall animal health. Its portfolio features calcium supplements, liver tonics, and digestive aids designed to meet the specific nutritional needs of dairy animals. The company utilizes research-driven formulations and quality-controlled manufacturing processes to provide effective solutions for livestock management. By prioritizing animal welfare and productivity, it supports the operational efficiency of dairy farming through scientifically developed nutritional interventions.

Recent filings

Filing Released Lang Actions
Board Meeting — Fund Raising
Board/Management Information Classification · 95% confidence The document is a short notice informing the stock exchange about an upcoming Board Meeting scheduled for December 31, 2024. It mentions the agenda to consider a proposal to raise funds and other matters. There is no detailed financial data, no report attached or referenced as published, and no certification or voting results. The document is an announcement related to the company's board activities, specifically a meeting notice. Therefore, it fits best under 'Board/Management Information' (MANG). The document length is short (1392 characters), consistent with a meeting notice rather than a full report or detailed filing.
2024-12-24 English
Board Meeting — Board Meeting Intimation
Regulatory Filings
2024-12-24 English
Reply to Clarification- Financial results
Regulatory Filings
2024-12-17 English
Updates
Regulatory Filings
2024-12-09 English
Updates
Regulatory Filings Classification · 95% confidence The document is a short announcement from Ajooni Biotech Limited addressed to the National Stock Exchange of India. It provides an update about the company's participation in two expos and mentions awards and achievements related to marketing and growth. There is no financial data, no mention of a report being attached or published, no regulatory or legal content, and no indication of a formal filing such as an annual report, earnings release, or management discussion. The document is informational and does not fit into categories like financial reports, governance, or capital changes. Given its nature as a general company update submitted to the stock exchange, it best fits the category of Regulatory Filings (RNS), which is the fallback for miscellaneous announcements that do not fit other categories. The document length is short (1598 characters), and it is clearly not a report publication announcement or certification. Therefore, the classification is RNS with high confidence.
2024-12-04 English
Press Release
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement of Ajooni Biotech's unaudited financial results for Q2 FY25 and H1 FY25, including key financial highlights such as total income, EBITDA, and PAT with year-on-year growth percentages. It contains commentary from the Managing Director on the financial performance and strategic developments. The document includes substantive financial data and analysis for a quarterly period, which aligns with the characteristics of an Interim / Quarterly Report. The length of the document (5322 characters) and the presence of actual financial figures and management commentary confirm it is a report rather than a brief announcement or a certification. Therefore, the appropriate classification is Interim / Quarterly Report (IR). Q2 2025
2024-11-18 English

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.